Room A
Educational session
Date
15.12.2018
Time
09:10 - 10:40
Location
Room A
Chairs
- J. B. Haanen (Amsterdam, Netherlands)
- A. Marabelle (Villejuif, France)
Immuno-oncology: State of the art I
Educational session
Session DOI (ID 510)
Lecture Time
09:10 - 09:10
Session Name
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
15.12.2018
Time
09:10 - 10:40
Immuno-oncology: State of the art I
Educational session
Arginase inhibition to modulate the TME: Rationale and early clinical experience (ID 104)
Lecture Time
09:10 - 09:30
Speakers
- S. Ioannidis (Epalinges, Not Applicable, Switzerland)
Session Name
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
15.12.2018
Time
09:10 - 10:40
Authors
- S. Ioannidis (Epalinges, Not Applicable, Switzerland)
Immuno-oncology: State of the art I
Educational session
When 1+1 = 3: Unlocking the potential of the IL-2 pathway with NKTR-214 in combination treatment (ID 103)
Lecture Time
09:30 - 09:50
Speakers
- J. Zalevsky (San Francisco, United States of America)
Session Name
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
15.12.2018
Time
09:10 - 10:40
Authors
- J. Zalevsky (San Francisco, United States of America)
Immuno-oncology: State of the art I
Educational session
Directing the immune system with neoantigen therapeutics (ID 106)
Lecture Time
09:50 - 10:10
Speakers
- R. B. Gaynor (Cambridge, Indianapolis, United States of America)
Session Name
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
15.12.2018
Time
09:10 - 10:40
Authors
- R. B. Gaynor (Cambridge, Indianapolis, United States of America)
Immuno-oncology: State of the art I
Educational session
ImmTACTM Platform: Novel bispecific high affinity TCR-effector fusions to modulate the immune system for the treatment of cancer (ID 105)
Lecture Time
10:10 - 10:30
Speakers
- L. Humbert (Abingdon, United Kingdom)
Session Name
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
15.12.2018
Time
09:10 - 10:40
Authors
- L. Humbert (Abingdon, United Kingdom)